287 related articles for article (PubMed ID: 32981380)
1. A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population.
Kangwanrattanakul K
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):765-774. PubMed ID: 32981380
[TBL] [Abstract][Full Text] [Related]
2. A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.
Sakthong P; Munpan W
Appl Health Econ Health Policy; 2017 Oct; 15(5):669-679. PubMed ID: 28290106
[TBL] [Abstract][Full Text] [Related]
3. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
4. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
[TBL] [Abstract][Full Text] [Related]
5. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
Kangwanrattanakul K; Parmontree P
Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
[TBL] [Abstract][Full Text] [Related]
6. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases.
Sakthong P; Sonsa-Ardjit N; Sukarnjanaset P; Munpan W
Qual Life Res; 2015 Dec; 24(12):3015-22. PubMed ID: 26048348
[TBL] [Abstract][Full Text] [Related]
8. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.
Xu RH; Dong D; Luo N; Wong EL; Wu Y; Yu S; Yang R; Liu J; Yuan H; Zhang S
Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029
[TBL] [Abstract][Full Text] [Related]
10. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.
Sayah FA; Qiu W; Xie F; Johnson JA
Qual Life Res; 2017 Aug; 26(8):2057-2066. PubMed ID: 28364183
[TBL] [Abstract][Full Text] [Related]
11. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
12. Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D.
Wang X; Luo H; Yao E; Tang R; Dong W; Liu F; Liang J; Xiao M; Zhang Z; Niu J; Song L; Fu L; Li X; Qian S; Guo Q; Song Z
Medicine (Baltimore); 2022 Nov; 101(45):e31666. PubMed ID: 36397330
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.
Xie S; Wang D; Wu J; Liu C; Jiang W
Health Qual Life Outcomes; 2022 Jun; 20(1):96. PubMed ID: 35710429
[TBL] [Abstract][Full Text] [Related]
14. Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students.
Zhou HJ; Zhang A; Wei J; Wu J; Luo N; Wang P
BMC Public Health; 2023 Nov; 23(1):2314. PubMed ID: 37993793
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
[TBL] [Abstract][Full Text] [Related]
16. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of Chinese medicine quality of life assessment scale (CQ-11D) and EQ-5D-5L and SF-6D scales based on Chinese population.
Zhou J; Xu L; Pan J; Wang M; Zhou P; Wang W; Lu S; Zhu W
Qual Life Res; 2024 Jan; 33(1):113-122. PubMed ID: 37695478
[TBL] [Abstract][Full Text] [Related]
18. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
Ye Z; Sun L; Wang Q
Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China.
Ding N; Zhou H; Chen C; Chen H; Shi Y
Appl Health Econ Health Policy; 2024 Jul; 22(4):555-568. PubMed ID: 38641755
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]